These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30503260)

  • 1. The MicroRNA-371 Family as Plasma Biomarkers for Monitoring Undifferentiated and Potentially Malignant Human Pluripotent Stem Cells in Teratoma Assays.
    Salvatori DCF; Dorssers LCJ; Gillis AJM; Perretta G; van Agthoven T; Gomes Fernandes M; Stoop H; Prins JB; Oosterhuis JW; Mummery C; Looijenga LHJ
    Stem Cell Reports; 2018 Dec; 11(6):1493-1505. PubMed ID: 30503260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In Vitro Pluripotency Assays.
    Bouma MJ; van Iterson M; Janssen B; Mummery CL; Salvatori DCF; Freund C
    Stem Cell Reports; 2017 May; 8(5):1340-1353. PubMed ID: 28494940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in Testicular Germ Cell Tumors: The Teratoma Challenge.
    Yodkhunnatham N; Pandit K; Puri D; Yuen KL; Bagrodia A
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells.
    Ben-David U; Arad G; Weissbein U; Mandefro B; Maimon A; Golan-Lev T; Narwani K; Clark AT; Andrews PW; Benvenisty N; Carlos Biancotti J
    Nat Commun; 2014 Sep; 5():4825. PubMed ID: 25198699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of pluripotent stem cell-derived teratoma formation by small molecules.
    Lee MO; Moon SH; Jeong HC; Yi JY; Lee TH; Shim SH; Rhee YH; Lee SH; Oh SJ; Lee MY; Han MJ; Cho YS; Chung HM; Kim KS; Cha HJ
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3281-90. PubMed ID: 23918355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivation of pluripotent stem cells from nascent undifferentiated teratoma.
    An Y; Sekinaka T; Tando Y; Okamura D; Tanaka K; Ito-Matsuoka Y; Takehara A; Yaegashi N; Matsui Y
    Dev Biol; 2019 Feb; 446(1):43-55. PubMed ID: 30529251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanised Mice and Immunodeficient Mice (NSG) Are Equally Sensitive for Prediction of Stem Cell Malignancy in the Teratoma Assay.
    Bialecka M; Montilla-Rojo J; Roelen BAJ; Gillis AJ; Looijenga LHJ; Salvatori DCF
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis.
    Gillis AJ; Stoop H; Biermann K; van Gurp RJ; Swartzman E; Cribbes S; Ferlinz A; Shannon M; Oosterhuis JW; Looijenga LH
    Int J Androl; 2011 Aug; 34(4 Pt 2):e160-74. PubMed ID: 21631526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are revealed during in vivo differentiation of partially reprogrammed human-induced pluripotent stem cells.
    Griscelli F; Féraud O; Oudrhiri N; Gobbo E; Casal I; Chomel JC; Biéche I; Duvillard P; Opolon P; Turhan AG; Bennaceur-Griscelli A
    Am J Pathol; 2012 May; 180(5):2084-96. PubMed ID: 22425713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional in vivo and in vitro effects of 20q11.21 genetic aberrations on hPSC differentiation.
    Jo HY; Lee Y; Ahn H; Han HJ; Kwon A; Kim BY; Ha HY; Kim SC; Kim JH; Kim YO; Kim S; Koo SK; Park MH
    Sci Rep; 2020 Oct; 10(1):18582. PubMed ID: 33122739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Magnetic Resonance Imaging and Serum Biomarkers for Detection of Human Pluripotent Stem Cell-Derived Teratomas.
    Riegler J; Ebert A; Qin X; Shen Q; Wang M; Ameen M; Kodo K; Ong SG; Lee WH; Lee G; Neofytou E; Gold JD; Connolly AJ; Wu JC
    Stem Cell Reports; 2016 Feb; 6(2):176-87. PubMed ID: 26777057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Validation Model for Informative Liquid Biopsy-Based microRNA Biomarkers: Insights from Germ Cell Tumor In Vitro, In Vivo and Patient-Derived Data.
    Lobo J; Gillis AJM; van den Berg A; Dorssers LCJ; Belge G; Dieckmann KP; Roest HP; van der Laan LJW; Gietema J; Hamilton RJ; Jerónimo C; Henrique R; Salvatori D; Looijenga LHJ
    Cells; 2019 Dec; 8(12):. PubMed ID: 31847394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential methylation of the OCT3/4 upstream region in primary human testicular germ cell tumors.
    De Jong J; Weeda S; Gillis AJ; Oosterhuis JW; Looijenga LH
    Oncol Rep; 2007 Jul; 18(1):127-32. PubMed ID: 17549357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teratoma Assay for Testing Pluripotency and Malignancy of Stem Cells: Insufficient Reporting and Uptake of Animal-Free Methods-A Systematic Review.
    Montilla-Rojo J; Bialecka M; Wever KE; Mummery CL; Looijenga LHJ; Roelen BAJ; Salvatori DCF
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology of childhood germ cell tumours, focussing on the significance of microRNAs.
    Murray MJ; Nicholson JC; Coleman N
    Andrology; 2015 Jan; 3(1):129-39. PubMed ID: 25303610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teratoma: from spontaneous tumors to the pluripotency/malignancy assay.
    Bulic-Jakus F; Katusic Bojanac A; Juric-Lekic G; Vlahovic M; Sincic N
    Wiley Interdiscip Rev Dev Biol; 2016; 5(2):186-209. PubMed ID: 26698368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-content screen in human pluripotent cells identifies miRNA-regulated pathways controlling pluripotency and differentiation.
    de Souza Lima IM; Schiavinato JLDS; Paulino Leite SB; Sastre D; Bezerra HLO; Sangiorgi B; Corveloni AC; Thomé CH; Faça VM; Covas DT; Zago MA; Giacca M; Mano M; Panepucci RA
    Stem Cell Res Ther; 2019 Jul; 10(1):202. PubMed ID: 31287022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards.
    Martin RM; Fowler JL; Cromer MK; Lesch BJ; Ponce E; Uchida N; Nishimura T; Porteus MH; Loh KM
    Nat Commun; 2020 Jun; 11(1):2713. PubMed ID: 32483127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-367 as a therapeutic target in stem-like cells from embryonal central nervous system tumors.
    Kaid C; Jordan D; Bueno HMS; Araujo BHS; Assoni A; Okamoto OK
    Mol Oncol; 2019 Dec; 13(12):2574-2587. PubMed ID: 31402560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.